TipRanks
BioRestorative Therapies (DE:9OF0)
FRANKFURT:9OF0
Germany Market
9OF0
BioRestorative Therapies
RESEARCH TOOLSreports

BioRestorative Therapies (9OF0) Income Statement

1 Followers

BioRestorative Therapies Income Statement

Last quarter (Q1 2026), BioRestorative Therapies's total revenue was $23.17K, a decrease of -7.32% from the same quarter last year. In Q1, BioRestorative Therapies's net income was $-2.15M. See BioRestorative Therapies’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 359.70K$ 401.00K$ 145.80K$ 119.80K$ 46.00K
Gross Profit
$ 335.86K$ 372.93K$ 145.80K$ 119.80K$ 46.00K
Operating Expenses
$ 15.98M$ 11.93M$ 15.37M$ 18.98M$ 26.35M
Depreciation and Amortization
$ 209.99K$ 189.06K$ 165.74K$ 120.55K$ 89.11K
EBITDA
$ -14.03M$ -8.79M$ -14.97M$ -13.10M$ -42.40M
Operating Income
$ -15.65M$ -11.56M$ -15.22M$ -18.86M$ -26.31M
Other Income/Expenses
$ 1.41M$ 2.58M$ 4.80M$ 5.64M$ -18.00M
Pretax Income
$ -14.24M$ -8.98M$ -10.42M$ -13.22M$ -44.30M
Net Income
$ -14.24M$ -8.98M$ -10.42M$ -13.22M$ -44.30M
Per Share Metrics
Basic EPS
$ -31.60$ -23.20$ -49.40$ -73.00$ -746.00
Diluted EPS
$ -31.60$ -23.20$ -49.40$ -73.00$ -746.00
Weighted Average Shares Outstanding
 449.66K 388.20K 210.92K 180.89K 59.39K
Weighted Average Shares Outstanding (Diluted)
 449.66K 388.20K 210.92K 180.89K 59.39K
Currency in USD

BioRestorative Therapies Earnings and Revenue History